219 related articles for article (PubMed ID: 18630870)
1. Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Garfunkle J; Ezzili C; Rayl TJ; Hochstatter DG; Hwang I; Boger DL
J Med Chem; 2008 Aug; 51(15):4392-403. PubMed ID: 18630870
[TBL] [Abstract][Full Text] [Related]
2. α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.
Duncan KK; Otrubova K; Boger DL
Bioorg Med Chem; 2014 May; 22(9):2763-70. PubMed ID: 24690529
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.
Boger DL; Miyauchi H; Du W; Hardouin C; Fecik RA; Cheng H; Hwang I; Hedrick MP; Leung D; Acevedo O; Guimarães CR; Jorgensen WL; Cravatt BF
J Med Chem; 2005 Mar; 48(6):1849-56. PubMed ID: 15771430
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.
Romero FA; Du W; Hwang I; Rayl TJ; Kimball FS; Leung D; Hoover HS; Apodaca RL; Breitenbucher JG; Cravatt BF; Boger DL
J Med Chem; 2007 Mar; 50(5):1058-68. PubMed ID: 17279740
[TBL] [Abstract][Full Text] [Related]
5. Binding and inactivation mechanism of a humanized fatty acid amide hydrolase by alpha-ketoheterocycle inhibitors revealed from cocrystal structures.
Mileni M; Garfunkle J; DeMartino JK; Cravatt BF; Boger DL; Stevens RC
J Am Chem Soc; 2009 Aug; 131(30):10497-506. PubMed ID: 19722626
[TBL] [Abstract][Full Text] [Related]
6. Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Kimball FS; Romero FA; Ezzili C; Garfunkle J; Rayl TJ; Hochstatter DG; Hwang I; Boger DL
J Med Chem; 2008 Feb; 51(4):937-47. PubMed ID: 18247553
[TBL] [Abstract][Full Text] [Related]
7. X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.
Mileni M; Garfunkle J; Ezzili C; Kimball FS; Cravatt BF; Stevens RC; Boger DL
J Med Chem; 2010 Jan; 53(1):230-40. PubMed ID: 19924997
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.
Rusch M; Zahov S; Vetter IR; Lehr M; Hedberg C
Bioorg Med Chem; 2012 Jan; 20(2):1100-12. PubMed ID: 22196515
[TBL] [Abstract][Full Text] [Related]
9. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
Holtfrerich A; Hanekamp W; Lehr M
Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
[TBL] [Abstract][Full Text] [Related]
10. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
11. Fluoride-mediated capture of a noncovalent bound state of a reversible covalent enzyme inhibitor: X-ray crystallographic analysis of an exceptionally potent α-ketoheterocycle inhibitor of fatty acid amide hydrolase.
Mileni M; Garfunkle J; Ezzili C; Cravatt BF; Stevens RC; Boger DL
J Am Chem Soc; 2011 Mar; 133(11):4092-100. PubMed ID: 21355555
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of fatty acid amide hydrolase inhibition by potent alpha-ketoheterocycle derivatives from Monte Carlo simulations.
Guimarães CR; Boger DL; Jorgensen WL
J Am Chem Soc; 2005 Dec; 127(49):17377-84. PubMed ID: 16332087
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.
Otrubova K; Cravatt BF; Boger DL
J Med Chem; 2014 Feb; 57(3):1079-89. PubMed ID: 24456116
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Hardouin C; Kelso MJ; Romero FA; Rayl TJ; Leung D; Hwang I; Cravatt BF; Boger DL
J Med Chem; 2007 Jul; 50(14):3359-68. PubMed ID: 17559203
[TBL] [Abstract][Full Text] [Related]
15. Reversible competitive α-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics.
Ezzili C; Mileni M; McGlinchey N; Long JZ; Kinsey SG; Hochstatter DG; Stevens RC; Lichtman AH; Cravatt BF; Bilsky EJ; Boger DL
J Med Chem; 2011 Apr; 54(8):2805-22. PubMed ID: 21428410
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Maryanoff BE; Costanzo MJ
Bioorg Med Chem; 2008 Feb; 16(4):1562-95. PubMed ID: 18053726
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH).
Chen Z; Hou L; Gan J; Cai Q; Ye W; Chen J; Tan Z; Zheng C; Li G; Xu H; Fowler CJ; Liang SH; Wang L
Bioorg Med Chem Lett; 2020 Nov; 30(21):127513. PubMed ID: 32860981
[TBL] [Abstract][Full Text] [Related]
18. Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
Timmons A; Seierstad M; Apodaca R; Epperson M; Pippel D; Brown S; Chang L; Scott B; Webb M; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2008 Mar; 18(6):2109-13. PubMed ID: 18289847
[TBL] [Abstract][Full Text] [Related]
19. Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Myllymäki MJ; Käsnänen H; Kataja AO; Lahtela-Kakkonen M; Saario SM; Poso A; Koskinen AM
Eur J Med Chem; 2009 Oct; 44(10):4179-91. PubMed ID: 19539407
[TBL] [Abstract][Full Text] [Related]
20. Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.
DeMartino JK; Garfunkle J; Hochstatter DG; Cravatt BF; Boger DL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5842-6. PubMed ID: 18639454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
